Pharmaceutical Payments to Japanese Board‐Certified Head and Neck Surgeons Between 2016 and 2019

Objective To evaluate the magnitude, prevalence, and trend of the financial relationship between Japanese head and neck surgeons and pharmaceutical companies between 2016 and 2019. Study Design Cross‐sectional analysis. Setting Japan. Methods This study evaluated personal payments concerning lecturi...

Full description

Saved in:
Bibliographic Details
Published in:OTO open : the official open access journal of the American Academy of Otolaryngology--Head and Neck Surgery Foundation 2023-01, Vol.7 (1), p.e31-n/a
Main Authors: Murayama, Anju, Shigeta, Haruki, Kamamoto, Sae, Yamashita, Erika, Saito, Hiroaki, Sawano, Toyoaki, Bhandari, Divya, Shrestha, Sunil, Kusumi, Eiji, Tanimoto, Tetsuya, Ozaki, Akihiko
Format: Article
Language:English
Subjects:
Binomial distribution
Cancer therapies
conflict of interest
Cross-sectional studies
Disclosure
Drugs
FDA approval
Head & neck cancer
head and neck cancer
Japan
Medical equipment
Original Research
Pharmaceutical industry
pharmaceutical payment
Surgeons
Surgery
Thyroid gland
Trends
Values
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Objective To evaluate the magnitude, prevalence, and trend of the financial relationship between Japanese head and neck surgeons and pharmaceutical companies between 2016 and 2019. Study Design Cross‐sectional analysis. Setting Japan. Methods This study evaluated personal payments concerning lecturing, consulting, and writing paid by 92 major pharmaceutical companies to all Japanese head and neck surgeons board‐certified by the Japan Society for Head and Neck Surgery between 2016 and 2019. The payments were descriptively analyzed and payment trend were assessed using population‐averaged generalized estimating equations. Further, the payments to board executive board members with specialist certification were also evaluated separately. Results Of all 443 board‐certified head and neck surgeons in Japan, 365 (82.4%) received an average of $6443 (standard deviation: $12,875), while median payments were $2002 (interquartile ranges [IQR] $792‐$4802). Executive board specialists with a voting right received much higher personal payments (median $26,013, IQR $12,747‐$35,750) than the non‐executive specialists (median $1926, IQR $765‒$4134, p 
ISSN:2473-974X
2473-974X
DOI:10.1002/oto2.31